BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 18570578)

  • 21. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
    Winston DJ; Bartoni K; Bruckner DA; Schiller GJ; Territo MC
    Clin Infect Dis; 1998 Mar; 26(3):576-83. PubMed ID: 9524826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Kuriyama T; Karasawa T; Nakagawa K; Nakamura S; Yamamoto E
    Oral Microbiol Immunol; 2002 Oct; 17(5):285-9. PubMed ID: 12354209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
    Paladino JA; Gilliland-Johnson KK; Adelman MH; Cohn SM
    Surg Infect (Larchmt); 2008 Jun; 9(3):325-33. PubMed ID: 18570574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
    Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
    Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections.
    Leal del Rosal P
    J Chemother; 1995 Jun; 7 Suppl 2():143-8. PubMed ID: 8622103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme.
    Cheng K; Newell P; Chow JW; Broadhurst H; Wilson D; Yates K; Wardman A
    Drug Saf; 2020 Aug; 43(8):751-766. PubMed ID: 32602065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
    Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
    Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan.
    Mikamo H; Matsumizu M; Nakazuru Y; Nagashima M
    J Infect Chemother; 2015 Feb; 21(2):96-104. PubMed ID: 25442806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial.
    Bradley JS; Broadhurst H; Cheng K; Mendez M; Newell P; Prchlik M; Stone GG; Talley AK; Tawadrous M; Wajsbrot D; Yates K; Zuzova A; Gardner A
    Pediatr Infect Dis J; 2019 Aug; 38(8):816-824. PubMed ID: 31306396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
    Khan S; Gupta DK; Khan DN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
    Boĭko VV; Ivanova IuV
    Klin Khir; 2012 Jan; (1):30-2. PubMed ID: 22642085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital.
    Koomanachai P; Tongsai S; Thamlikitkul V
    J Med Assoc Thai; 2016 Jan; 99(1):8-14. PubMed ID: 27455819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.